Vir Biotechnology Files 8-K on Officer Changes & Compensation
Ticker: VIR · Form: 8-K · Filed: Feb 20, 2024 · CIK: 1706431
| Field | Detail |
|---|---|
| Company | Vir Biotechnology, Inc. (VIR) |
| Form Type | 8-K |
| Filed Date | Feb 20, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, compensation, 8-K
TL;DR
**Vir Biotechnology just filed an 8-K about changes in its executive team and their pay, so keep an eye on leadership shifts!**
AI Summary
Vir Biotechnology, Inc. filed an 8-K on February 20, 2024, reporting an event that occurred on February 19, 2024. The filing pertains to Item 5.02, specifically regarding the departure or election of directors or officers and compensatory arrangements for certain officers. The company, based in San Francisco, CA, operates in the biological products industry.
Why It Matters
This filing signals potential shifts in leadership or executive compensation at Vir Biotechnology, which could impact the company's strategic direction and financial health.
Risk Assessment
Risk Level: medium — Changes in executive leadership and compensation can introduce uncertainty regarding future company performance and strategy.
Key Players & Entities
- Vir Biotechnology, Inc. (company) — Registrant
- February 19, 2024 (date) — Date of earliest event reported
- February 20, 2024 (date) — Filing date
- San Francisco, California (location) — Principal executive offices
- 001-39083 (other) — Commission File Number
FAQ
What was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 19, 2024.
What is the primary subject matter of this 8-K filing?
The primary subject matter of this 8-K filing is Item 5.02, which covers the Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
What is the full name of the registrant company?
The full name of the registrant company is Vir Biotechnology, Inc.
Where are Vir Biotechnology, Inc.'s principal executive offices located?
Vir Biotechnology, Inc.'s principal executive offices are located at 1800 Owens Street, Suite 900, San Francisco, California 94158.
What is the registrant's Commission File Number?
The registrant's Commission File Number is 001-39083.
Filing Stats: 421 words · 2 min read · ~1 pages · Grade level 11 · Accepted 2024-02-20 16:33:11
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value VIR Nasdaq Global Select
Filing Documents
- d793408d8k.htm (8-K) — 21KB
- 0001193125-24-040034.txt ( ) — 139KB
- vir-20240219.xsd (EX-101.SCH) — 3KB
- vir-20240219_lab.xml (EX-101.LAB) — 18KB
- vir-20240219_pre.xml (EX-101.PRE) — 11KB
- d793408d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VIR BIOTECHNOLOGY, INC. Date: February 20, 2024 By: /s/ Sung Lee Sung Lee Chief Financial Officer